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Brain stem tumors in children -  therapeutic results in patients 
of the University Children’s Hospital of Cracow in Poland
Elżbieta Korab-Chrzanowska1, Stanisław Kwiatkowski2,
Joanna Bartoszewska1
A im . To analyse the treatment results achieved in children treated for brain stem tumours at one institution between the years 
1990 and 2004.
M a t e r i a l  20 patients (10 girls, 10 boys) aged 2.8-15.6 years were treated for brain stem tumors at the University Children’s 
Hospital o f Cracow (UCHC) in the years 1990-2004.
The tumour type was defined basing on imaging studies (CT, MRI), and, in the case o f 7patients, additionally basing on 
histopathological results. In the collected material the predominant tumor type was benign glioma, detected in 17patients. 
Malignant gliomas were diagnosed in 3 children.
M e t h o d .  7 children were treated by radiotherapy only. Surgical procedures and adjuvant radiotherapy were employed in 3 
patients. 6 children underwent radiotherapy and chemotherapy. Combined surgical treatment followed by radiotherapy and 
chemotherapy was employed in 4 patients.
R esu l t s .  O f the 20 patients 6 have died (30%). The surviving group (70%) includes 1 patient with tumor progression (5%), 
5 -  with stable tumors (25%), and 8 (40%) -  with tumor regression. The probability o f three-year overall survival for the 
entire group as calculated by the Kaplan-Meier method was 70% while the probability o f three-year progression-free survival 
was 65%.
C o n c l u s i o n s .  Diffuse brain stem tumors, mostly those involving the pons, and malignant gliomas have poor prognosis. In 
the presented material we achieved the best treatment results in patients with exophytic or focal tumors, treated surgically with 
adjuvant therapy.
Guzy pnia mózgu u dzieci -  wyniki leczenia w materiale 
Uniwersyteckiego Szpitala Dziecięcego w Krakowie
Wprowadzenie. 20 pacjentów (10 dziewczynek i 10 chłopców) w wieku 2,8-15,6 lat z  nowotworami pnia mózgu było 
leczonych w Uniwersyteckim Szpitalu Dziecięcym (USD) w Krakowie w latach 1990-2004.
C e l pracy .  Ocena wyników leczenia dzieci z  nowotworami pnia mózgu w materiale USD.
Mater ia ł .  Na podstawie badań obrazowych (KT, NMR), a u 7  pacjentów dodatkowo w oparciu o badanie histopatologiczne, 
określono typ nowotworu. W  materiale własnym przeważały guzy o charakterze glejaka łagodnego: u 17 pacjentów. Glejaki 
złośliwe zdiagnozowano u 3 dzieci.
M e to d a .  Samą radioterapią leczono 7 dzieci. Chirurgię z  następową radioterapią zastosowano u 3 pacjentów. Radioterapię 
z  chemioterapią stosowano u 6 dzieci. Skojarzonemu leczeniu operacyjnemu z  następową radio- i chemioterapią poddano 
4 pacjentów.
Wynik i .  Z  20 pacjentów leczonych w Uniwersyteckim Szpitalu Dziecięcym w Krakowie w latach 1990-2004 z  powodu guzów 
pnia mózgu, 6 zmarło (30%), a 14 pacjentów żyje (70%), w tym 1 z  progresją choroby (5%), 5 ze stabilizacją (25%) oraz 
8 z  regresją guza (40%). Prawdopodobieństwo przeżycia 3 letniego całkowitego oraz 3 letniego bez progresji choroby oceniono 
na podstawie krzywych przeżyć Kaplana-Meiera; wyniosło ono dla przeżyć całkowitych 70%, a dla przeżyć bez progresji 
choroby 65%.
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W n i o s k i .  Rozlane guzy pnia, głównie mostu oraz złośliwe glejaki charakteryzuje złe rokowanie. W  materiale własnym 
najlepsze wyniki osiągnięto u pacjentów z  guzami o charakterze egzofitycznym lub ogniskowym, leczonych operacyjnie 
z  następowym leczeniem uzupełniającym.
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Introduction
More than 70% of tumors situated in the brain stem -  in 
the mesencephalon, the pons and the medulla oblongata 
-  are encountered in patients below 20 years of age [1]. 
They account for 10 to 20% of brain tumors in children; 
in the present material this ratio reached 14% (20 patients 
treated  in the years 1990-2004). In the U nited States 
some 150-300 cases are detected annually [1, 2]. These 
tumors are most common in the 7-9 years age group and 
show no significant difference in their distribution 
between both sexes. Histologically, the predominant type 
is glioma with varying degrees of malignancy. Other brain 
stem tumors include PNET, lymphomas, cavernomas and 
epidermal cysts [1, 3]. In neurological and neurosurgical 
practice we use the classification presented by Epstein. It 
classifies these tumors as diffuse, focal, cystic, exophytic 
and tumors of the craniovertebral region [4].
Clinical symptoms vary according to tum or type, 
location and patient age. In exophytic tum ors of the 
fourth ventricle and the tectal lamina, the predominant 
symptoms include intracranial hypertension associated
with hydrocephalus. In diffuse tumors, especially involving 
the brain stem, the clinical symptoms develop rapidly and 
include balance problems, muscular hypotonia, dysmetria 
and cranial nerve damage. In tum ors involving the 
m edulla oblongata and the cervical segment of the 
medulla, the frequently encountered symptoms include 
persistent hiccups, recurrent infections of the upper 
respiratory tract, changed timbre of voice and altered 
way of speaking. All groups of brain stem tumors are 
characterized by such initial symptoms as eye movement 
abnormalities -  divergent squint with or without double 
vision, abnormal accommodation and Parinaud’s sign. 
The management of brain stem tumors includes surgery, 
radiotherapy and chemotherapy, or a combination of 
these therapeutic modalities.
Objective
To sum up and assess the therapeutic results achieved in 
children with brain stem tum ors m anaged at the 
University Children’s Hospital of Cracow in the years 
1990-2004.
Table I. Patient and disease characteristics
Age Gender Histopathology Tumor 
growth type
Therapeutic
modalities
Assessment 
of response 
to therapy
A.W 6.1 M None diffuse RT P, death
K.S 6.0 M None diffuse RT CR
T.J 12.6 F None exophytic RT CR
C.G 4.7 M None exophytic RT PR
S.P 6.1 F None focal RT P, death
P.P 13.0 F None focal RT P, death
P.M 15.6 F None focal RT PR
R.N 14.1 M a. fibrillare partim  bipolare focal O P+R T S
Ż.M 14.6 F a. fibrillare partim  bipolare focal O P+R T S
Z.D 9.5 M a. pilocyticum exophytic O P+R T S
Ł.D 11.1 M None diffuse C H T+R T CR
W.D 13.1 F None exophytic C H T+RT PR
M.E 11.9 F None exophytic C H T+R T P, death
S.E 13.6 F None focal C H T+R T PR
M.S 13.0 M None focal C H T+R T S
F.A 4.3 M None focal C H T+R T P, death
H.T 4.8 M a. pilocyticum exophytic O P + C H T + R T S
S.Ł 13.6 M a. pilocyticum exophytic O P + C H T + R T P, death
B.K 2.8 F a. fibrillare partim  bipolare exophytic O P + C H T + R T PR
R.M 8.1 F a. fibrillare partim  bipolare exophytic O P + C H T + R T P
Legend: CR  -  complete regression, PR  -  partial regresssion, S -  stabilization, P -  progression
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Material
Between 1990 and 2004, 20 children aged from 2.8 to 15.6 years 
were treated at the University Children’s Hospital of Cracow; the 
group was equally divided into boys and girls. Prior to treatment, 
all the children underw ent CT scans, and 12 patients were 
additionally diagnosed using MRI, thus confirming the presence 
of a tum or in the brain stem. The tum our type was pronounced 
basing on the imaging studies and, in the case of the 7 surgical 
patients, additionally basing on histopathology. Table I presents 
the patient characteristics.
Method
7 children underwent surgical treatm ent followed by adjuvant 
therapy -  subsequent radiotherapy in 3 cases and radiotherapy 
and chem otherapy in 4 cases. D ue to inoperable disease, 13 
children were treated conservatively -  7 by radiotherapy alone, 
and 6 by radiotherapy and chemotherapy.
C o n s e r v a t i v e  t r e a t m e n t
Radiotherapy was employed in 7 children (age at diagnosis: 4.7­
15.6 years) -  3 boys and 4 girls. Surgical intervention consisted of 
implanting a ventriculo-peritoneal valve and was performed in 4 
children. D ue to tum or location the patients did not qualify for 
tum or resection. Prior to treatm ent, all the patients presented 
with neurological symptoms, which depended on tumor location. 
Pronounced personality changes, manifested as aggression and 
anxiety, were observed in one child with a lesion situated in the 
pons. Deterioration of the clinical and the neurological status in 
the course of therapy was noted in one child; this phenomenon 
was associated with massive progression of the disease and the 
treatm ent was discontinued.
In the course of treatm ent, the rem aining patients 
manifested considerable clinical and neurological improvement, 
including a girl, in whom disease progression occurred 4 months 
after the completion of therapy.
R a d i o t h e r a p y  a n d  c h e m o t h e r a p y
The treatm ent was employed in 6 patients aged between 4.3 
and 13.6 years -  3 girls and 3 boys. Surgical procedures 
(implantation of a ventriculo-peritoneal valve) were performed 
in 3 children. D ue to the detection of astrocytoma cells in the 
cerebrospinal fluid, one child was subjected to irradiation of 
the entire central nervous system, with an increased dose applied 
to the tumor site. Following preliminary chemotherapy according 
to the protocol established by the Polish Pediatric CNS Tumor 
G roup, 2 children m anifested massive tum or growth. Since 
a surgical intervention was impossible, the patients underwent 
radiotherapy. During the irradiation therapy, the children had 
already considerably improved clinically and neurologically, 
while CT scans showed tumor regression.
S u r g e r y  c o m b i n e d  w i t h  s u b s e q u e n t  
a d j u v a n t  t h e r a p y
Surgical procedures with subsequent radiotherapy were 
employed in 3 children -  2 boys and a girl -  aged 9.5-14.6 years.
S u r g e r y  w i t h  r a d i o t h e r a p y  a n d  
c h e m o t h e r a p y
The group included 4 children aged 2.8-13.6 years (2 boys and 2 
girls). In all these children partial tum or resection procedures 
were perform ed and followed by chem otherapy and radio­
therapy. Two patients managed in the earlier period were treated
according to the VCR + CCNU protocol, one child was on 
Temodal, and one was m anaged according to the protocol 
established by the Polish Pediatric CNS Tumor Group.
Results
Of the twenty patients treated at the University Children’s 
H ospital of Cracow due to brain stem tum ors in the 
period 1990-2004, 6 died (30%) and 14 survived (70%) -  
1 patient with tumor progression (5%), 5 -  with stabilized 
tumors (25%) and 8 (40%) -  with tumor regression. In 
the latter group 5 children demonstrate partial, and 3 -  
com plete tum or regression. Partial tum or resection 
procedures were performed in 7 children. Radiotherapy 
was employed in all 20 patients. In addition, chem o­
therapy was employed in 10 children. Long-term survivals 
(10 and 14 years) were achieved in 2 patients. These 
children had exophytic gliomas involving the pons and 
the pons and medulla oblongata, which were treated by 
radiotherapy alone, resulting in one total and one partial 
regression of the tum or, m aintained for 6 years and 
8 months, respectively. The latter child was subsequently 
operated on due to a recurrent tumor. At present, 14.5 
years after treatm ent completion, the patient is alive and 
symptom-free. 3 children achieved total survival ranging 
from 5 to 9 years. Two of these patients had partial tumor 
resection, followed by adjuvant irradiation therapy. One 
patient with a focal glioma of the medulla oblongata is 
alive, with stabilized disease m aintained for 5 years, 
another child with an exophytic glioma involving the 
medulla oblongata and pons was operated on after a 5- 
year stabilization period due to a recurrent tumor; this 
patient is presently (9.2 years after the initial diagnosis) 
alive and symptom-free.
Particularly worthy of consideration is a patient with 
an exophytic tumor of the mesencephalon and pons, in 
whom -  following surgical tumor tissue collection (no 
neoplastic cells were demonstrated in the material) and 
implantation of a ventriculo-peritoneal valve -  only one 
cycle of CCN U +V CR chemotherapy was administered. 
In view of the deteriorating general condition of the child, 
adjuvant therapy was discontinued and the patient was 
referred for symptomatic treatm ent. Over a period of 
two years, CT demonstrated spontaneous shrinking of the 
tum or mass and the child improved clinically and 
neurologically. A fter that, the disease progressed and 
irradiation therapy was employed, resulting in a moderate 
regression of the tum or as dem onstrated by imaging 
techniques, and in view of considerable clinical impro­
vement. After another three years, the disease progressed 
and the tumor was partially resected (histopathological 
diagnosis: astrocytoma pilocyticum). At present, 6.8 years 
after the onset of symptoms, the patient is alive and in 
a very good general condition, his disease is stabilized, 
which has been confirmed by imaging studies.
Survival curves for the entire group were generated 
by the Kaplan-Meier method. (Figures 1, 2). The length 
of survival was calculated from the data of diagnosis. The
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Table II. Mean total and event-free survivals 
in particular therapeutic groups
Number 
of patients
Therapeutic modalities PFS
(years)
OS
(years)
13 Conservative treatment: 
RT and R T+CH T 3.8 3.9
7 Surgery with adjuvant treatment: 
O P+R T  and O P + C H T + R T 4.5 4.7
Legend: PFS -  progression free survival, OS -  overall survival
survival length in particular therapeutic groups is 
demonstrated in Table II.
Discussion
Brain stem tumors pose a serious therapeutic problem. In 
spite of the development of neurosurgical techniques, 
often a radical or even a partial procedure is impossible to 
perform in the case of tumors situated in the pons or in 
the case of the so-called diffuse brain stem gliomas. Five-
Figure 1. Kaplan-Meier overall survival analysis
Figures 2. Kaplan-Meier progression -  free survival analysis
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year survival rates in this group oscillate between 10 and 
30% [1]. In our m aterial there were 4 patients with 
tum ors located in the pons, 5 with tum ors in the 
mesencephalon, and 6 -  in the medulla oblongata. In 
the case of 2 children, the tum or infiltrated the pons 
and the m edulla oblongata, in 3 -  the pons and the 
mesencephalon.
In view of the composition of the patient group, 
which included children mostly with advantageous 
location of the tum or, our results (85% children with 
advantageous location) are similar to those presented in 
literature. As follows from numerous reports published in 
medical periodicals, which of necessity are scarce in view 
of the relatively low incidence of the disease, to date, in 
random ized m ulticenter clinical trials based on large 
groups of patients no effective therapeutic modality has 
been identified which would ensure a high percentage of 
event-free survival. Surgical management continues to 
play a leading role only in patients with exophytic 
tumours. Radiotherapy is also a therapeutic standard, 
especially for diffuse tumors. Unfortunately, investigations 
on the use of hyperfractionated, accelerated and 
hyperfractionated accelerated radiation therapy have not 
contributed to an improvement in the outcomes [5, 6]. 
Therapeutic results have also failed to improve -  as may 
be seen from the group of 28 children subjected to 
brachytherapy with I-125 implants in whom the dose of 
82.9 Gy was employed [7]. In adult patients with brain 
stem tumors, investigations concentrate on stereotactic 
radiotherapy [8].
The use of chemotherapy in managing brain stem 
tumors in children is the subject of numerous clinical 
trials; unfortunately, at present only phase I or II. Thus, 
the Children’s Cancer Group (CCG) has been testing 
Toptecan as a radiosensitizer administered in combination 
with conventional radiotherapy. In the phase I clinical 
trial, the 1-year survival rate in 17 children was 53% [9]. 
Phase II results of the same study carried out by CCG 
were published in 2002; the trial included 63 children 
random ized into two groups. G roup 1 received three 
cycles of chem otherapy (carboplatin, etoposide and 
vincristin), while Group 2 was administered three cycles of 
cisplatin, etoposide, cyclophosphamide and vincristin. In 
both groups, chem otherapy was employed prior to 
hyperfractionated radiation therapy. In Group 1, 10±5% 
children responded to chemotherapy. After radiotherapy, 
the percentage of responders increased to 27% ±9% . In 
Group 2, a response to chemotherapy was achieved in 
19%±8%. After radiotherapy, however, the percentage 
increased to 23% ±9% . The 1-year event-free survival 
rate for all patients equaled 17% ±5% , while the 2-year 
survival rate was 6 % ± 3 %  [10]. Also in clinical trials 
perform ed by French investigators on 38 children and 
published in 2002, two cycles of carboplatin administered 
prior to irradiation and followed by carboplatin employed 
simultaneously with conventional radiotherapy failed to 
improve survival rates [11].
In our m aterial, the largest group (17 patients) 
consisted of children with brain stem tumors with the
type of growth that is associated with a more favorable 
prognosis -  exophytic or focal. Three children had the 
so-called diffuse brain stem glioma. When comparing the 
survivals as calculated from the onset of therapy in 
particular therapeutic groups, one notes that the longest 
survivals were achieved in patients with exophytic or focal 
tumors, who were treated  surgically and subjected to 
adjuvant radio- or chemo- and radiotherapy. However, 
the analyzed groups were small and not uniform  in 
character, and thus did not facilitate an objective 
assessment of the material.
W hat is striking in our 14 survivors is their good 
general and neurological state. All the children resumed 
schooling. Three patients presently attend primary schools 
(two of them are taught individually at home), while five 
continue their secondary level education, including two 
patients taught in the individual system. Four patients 
have com pleted secondary level education; one boy 
is a university student. Due to disease progression, one 
patient is unable to continue education. In the group 
of patients which we have been following up, three 
years after radiotherapy com pletion, 60% of school­
children have started  to experience problem s with 
memorizing text. However, with an increased effort on the 
part of the patients, teachers and parents, their school 
perform ance continues to be good, and allows to 
complete secondary school and even commence university 
education. Serious complications of the therapy include 
endocrine abnormalities. In the majority of cases such 
disturbances include deficits of thyroid hormones, sex 
horm ones and the growth horm one, which require 
substitution therapy. In the present material, the authors 
have not observed hearing loss, which has been reported 
by other investigators [12]. As follows from the publi­
cations on the subject, long-term  survival rates are 
achieved in children with cystic and exophytic tumors, in 
case of which partial or subtotal tum orectom ies are 
possible and can be followed by adjuvant therapy [2]. In 
these cases the long-term survival rates are above 50%. 
Our results are comparable with data reported by various 
authors, however, our group of patients is small and non- 
homogenous.
Conclusions
1. Brain stem tumors constitute a heterogeneous group of 
neoplasms characterized by a variable degree of 
biological malignancy.
2. Data obtained in M RI studies and from the clinical 
presentation have allowed to establish a classification 
of these tum ors and to develop a m anagem ent 
protocol.
3. In the vast majority of our patients (17), brain stem 
tumors are focal and exophytic in character. In such 
patients, long-term survivals are achieved.
4. Diffuse brain stem tumors, mostly involving the pons 
(80%), as well as malignant gliomas are associated 
with poor prognosis (3 patients in our material)
5. In our material, the best results have been achieved in
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patients, in whom tum or resections were possible, 
(even if the procedure was partial) and then were 
followed by adjuvant therapy.
6. The probability of three-year overall survival for our 
patients was 70%, and progression- free-survival was 
65%.
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